Coronavirus vaccine trials will begin Monday, with at least one subject receiving a first-ever experimental dose of the potential inoculation, a government official said.
Throughout the trial — funded by the National Institutes of Health — 45 young, healthy volunteers will receive different doses of shots co-developed by the NIH and the Massachusetts-based biotech firm Moderna Inc.
Plans to test the first participant have not been publicly announced, but the official disclosed the information to the Associated Press on the condition of anonymity.
Participants are not at risk of being infected with the bug-- excerpt, rest at link above --